AI health management for epilepsy in rural areas
Part of Brain & nervous system clinical trials.
This trial tests a smartphone-based AI system to help manage epilepsy long-term in rural areas. It is for people who have had at least one convulsive seizure in the past year and can use a smartphone with a caregiver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have epilepsy, as diagnosed by a doctor using current standards.
- You have had one or more convulsive seizures (where you lose consciousness and have shaking) in the last 12 months.
- You are between 18 and 65 years old.
- You or a caregiver must have a smartphone that you can use regularly.
- You are not pregnant, planning pregnancy, or breastfeeding.
- You do not have seizures caused by things like stopping alcohol suddenly.
- You are not allergic to the seizure medicines phenobarbital or sodium valproate.
- You do not have other serious health problems like organ failure, cancer, or severe mental illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile app that uses artificial intelligence to help people with epilepsy remember to take their anti-seizure medication. It is for teens and young adults (ages 14-24) living in Florida who are from underserved communities.
This trial tests a smart management system to improve care at community health centers. If you get care at a community clinic, you may be able to join.
This study tests an AI-powered program that helps doctors manage cancer patients who also have other health conditions. You may be able to join if you are starting or currently receiving cancer treatment and can use a smart device.
This trial tests whether a computer system can help doctors diagnose epilepsy more accurately by analyzing EEG (brain wave) recordings in children. It may be an option if your child has suspected seizures.
This trial tests a care pathway that includes remote monitoring and support from a nurse after you start a new anti-epileptic medication. It aims to see if this approach helps you manage your treatment changes more safely and conveniently.
This trial tests a mobile app called EPIDAY that gives you a daily forecast of your seizure risk. It is designed for people with focal epilepsy who have seizures at least two days a month.
Hear when a new Epilepsies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.